阻断性抗合成酶综合征中的介质素6抑制:基于病例的文献综述
Anna Driesen1, Jean-Baptiste Vulsteke2, Luk Corluy3
1Division of Dermatology, University Hospitals Leuven, Leuven, Belgium.
Acta clinica Belgica
|March 7, 2025
概括
干白素6 (IL-6) 抑制剂,托西利祖马布和沙利祖马布,在传统疗法失败时,在治疗抗合成酶综合征 (ASyS) 中表现有前途. 这些生物修饰性抗风湿药物 (bDMARDs) 改善了患者的症状,并减少了对皮质类固醇的依赖.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 抗合成酶综合征 (ASyS) 是一种罕见的特异性炎症性肌肉病 (IIM),具有重大诊断挑战.
- 皮质类固醇是主要的治疗方法,常常被免疫抑制剂补充.
- 生物修饰性抗风湿药物 (bDMARDs) 正在研究耐火病例,重点是IL-6抑制.
研究的目的:
- 评估IL-6抗剂在对传统治疗无反应的ASyS患者的疗效和安全性.
- 评估IL-6阻塞作为ASyS中的类固醇节约策略的潜力.
主要方法:
- 关于两名ASyS患者的病例报告.
- 用托西利祖马布和沙利祖马布 (IL-6抗剂) 治疗.
- 评估临床症状,实验室参数和肺功能.
主要成果:
- 这两位患者都经历了显著的临床改善.
- 实验室和肺部参数显示出积极的变化.
- 观察到额外的皮质类固醇节约效应.
- 治疗被很好地容忍.
结论:
- 用托西利祖马布和沙利祖马布抑制IL-6似乎在选择的ASyS患者中有效.
- 进一步的随机临床试验是有必要的,以确认在这个IIM子组的疗效.
相关概念视频
The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58


